Search results

Found 2,264 pages
AUTHOR: Lynne Taylor

Results per page

10 20 50 100

Sort by

Relevance Date

21 Feb 2014:

China's pharma export trade growth slows

China’s exports of pharmaceutical products increased 6.84% last year, but its imports of such products rose 6.84%, according to new industry figures. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/chinas_pharma_export_trade_growth_slows_1001565

7 Sep 2009:

EU pledge to India over drug seizures

The European Commission has told India it will take steps to end the seizures of Indian-made generic drugs at EU ports, but would prefer not to do so through a legal battle at the World Trade Organization (WTO). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/eu_pledge_to_india_over_drug_seizures_983696

9 Dec 2013:

EU pharma patent settlements continuing to rise

183 patent settlements between originator and generic drugmakers were concluded in the European Union (EU) in 2012, compared to 120 in 2011, but last year’s total drops to 125 when those relating to new legal provisions in Portugal are excluded. -

by Lynne Taylor

https://www.pharmatimes.com/news/eu_pharma_patent_settlements_continuing_to_rise_1006147

25 Sep 2009:

US Senate vote saves pharma deal

The US Senate Finance Committee has rejected a proposal to abandon the $80 billion cost-saving deal agreed in June between drugmakers and the panel’s chairman, Senator Max Baucus. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/us_senate_vote_saves_pharma_deal_983585

6 Aug 2008:

MHRA: new procedure for company name changes

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced a new procedure for companies that intend to change their name. The changes will not only apply to companies or legal entities which hold authorisations under the UK

by Lynne Taylor

https://www.pharmatimes.com/news/mhra_new_procedure_for_company_name_changes_988132

27 Oct 2013:

GPs urged over long-term conditions

GPs need to play a stronger role in coordinating care for people with long-term or chronic conditions, The King’s Fund has urged. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/gps_urged_over_long-term_conditions_1005915

11 Apr 2011:

UAE doubles pharma spending

The United Arab Emirates (UAE)’s national fund for the purchase of medicines has doubled, from 150 million dirhams in 2010 to 300 million dirhams for this year.  - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/uae_doubles_pharma_spending_979288

17 Dec 2013:

First-ever data on children with cancer in UK

New research, believed to be the first of its kind to be produced anywhere in the world, shows how many children in the UK aged 0-14 are currently living with a diagnosis of cancer. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/first-ever_data_on_children_with_cancer_in_uk_1006194

2 Feb 2012:

NICE draft "no" for Zytiga

The National Institute for Health and Clinical Excellence has issued new draft guidance not recommending the use of Janssen's Zytiga (abiraterone) in combination with prednisone or prednisolone for the treatment of castration-resistance metastatic

by Lynne Taylor

https://www.pharmatimes.com/news/nice_draft_no_for_zytiga_975799

22 Jul 2013:

French pharma sales drop in 2012

France's pharmaceutical market fell 1.5% to 27.2 billion euros in 2012, a decline driven by a 2.8% drop in pharmacy sales, say new official figures. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/french_pharma_sales_drop_in_2012_1005407